DK3421458T3 - Benzo-fusionerede heterocykliske derivater som kan anvendes som agonister af gpr120 - Google Patents

Benzo-fusionerede heterocykliske derivater som kan anvendes som agonister af gpr120 Download PDF

Info

Publication number
DK3421458T3
DK3421458T3 DK18169050.4T DK18169050T DK3421458T3 DK 3421458 T3 DK3421458 T3 DK 3421458T3 DK 18169050 T DK18169050 T DK 18169050T DK 3421458 T3 DK3421458 T3 DK 3421458T3
Authority
DK
Denmark
Prior art keywords
fusioned
benzo
heterocyclic derivatives
gpr120 agonists
gpr120
Prior art date
Application number
DK18169050.4T
Other languages
English (en)
Inventor
Zhihua Sui
Nalin L Subasinghe
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of DK3421458T3 publication Critical patent/DK3421458T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/64Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
DK18169050.4T 2013-03-14 2014-03-07 Benzo-fusionerede heterocykliske derivater som kan anvendes som agonister af gpr120 DK3421458T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361783118P 2013-03-14 2013-03-14
EP14715479.3A EP2970157B1 (en) 2013-03-14 2014-03-07 Benzo-fused heterocyclic derivatives useful as agonists of gpr120

Publications (1)

Publication Number Publication Date
DK3421458T3 true DK3421458T3 (da) 2020-12-14

Family

ID=50439484

Family Applications (2)

Application Number Title Priority Date Filing Date
DK18169050.4T DK3421458T3 (da) 2013-03-14 2014-03-07 Benzo-fusionerede heterocykliske derivater som kan anvendes som agonister af gpr120
DK14715479.3T DK2970157T3 (da) 2013-03-14 2014-03-07 Benzo-kondenserede heterocykliske derivater anvendelige som agonister af gpr120

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK14715479.3T DK2970157T3 (da) 2013-03-14 2014-03-07 Benzo-kondenserede heterocykliske derivater anvendelige som agonister af gpr120

Country Status (19)

Country Link
US (4) US9562053B2 (da)
EP (2) EP2970157B1 (da)
JP (2) JP6479751B2 (da)
KR (2) KR102422559B1 (da)
CN (1) CN105209444B (da)
AU (2) AU2014241397B2 (da)
BR (2) BR122021021616B1 (da)
CA (1) CA2905293C (da)
DK (2) DK3421458T3 (da)
EA (1) EA027781B1 (da)
ES (2) ES2836053T3 (da)
IL (2) IL240643B (da)
MX (1) MX2015012094A (da)
NZ (2) NZ751217A (da)
PH (2) PH12015501941B1 (da)
PL (2) PL3421458T3 (da)
SG (2) SG11201507240RA (da)
UA (2) UA117241C2 (da)
WO (1) WO2014159061A2 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA027781B1 (ru) 2013-03-14 2017-08-31 Янссен Фармацевтика Нв Бензоконденсированные гетероциклические производные, подходящие для использования в качестве агонистов gpr120
JP7065081B2 (ja) 2016-09-12 2022-05-11 インテグラル ヘルス, インコーポレイテッド Gpr120モジュレーターとして有用な二環式化合物
US10800773B2 (en) 2016-09-12 2020-10-13 Integral Health, Inc. Monocyclic compounds useful as GPR120 modulators
CA3090445A1 (en) 2018-03-15 2019-09-19 Axxam S.P.A. Substituted pyrazoles ffa4/gpr120 receptor agonists
CN111153841A (zh) * 2020-01-22 2020-05-15 广东工业大学 一种巯基功能化有机芳香羧酸配体及其制备方法与应用
CN111233724A (zh) * 2020-01-22 2020-06-05 广东工业大学 一种巯基功能化有机芳香羧酸配体及其制备方法与应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004041266A1 (ja) 2002-11-08 2004-05-21 Takeda Pharmaceutical Company Limited 受容体機能調節剤
AU2003296405A1 (en) * 2003-01-06 2004-08-10 Eli Lilly And Company Fused heterocyclic derivatives as ppar modulators
JP4922615B2 (ja) * 2003-11-26 2012-04-25 武田薬品工業株式会社 受容体機能調節剤
EP1706386A1 (en) * 2003-12-22 2006-10-04 Eli Lilly And Company Bicyclic derivatives as ppar modulators
RU2006126978A (ru) 2003-12-25 2008-01-27 Такеда Фармасьютикал Компани Лимитед (Jp) Производные 3-(4-бензилоксифенил)пропановой кислоты
EP1731505B1 (en) 2004-03-30 2015-01-14 Takeda Pharmaceutical Company Limited Alkoxyphenylpropanoic acid derivatives
EP2064193A1 (en) 2006-09-07 2009-06-03 Amgen, Inc Heterocyclic gpr40 modulators
US7687526B2 (en) 2006-09-07 2010-03-30 Amgen Inc. Benzo-fused compounds for use in treating metabolic disorders
KR20090077051A (ko) 2006-09-29 2009-07-14 액테리온 파마슈티칼 리미티드 3-아자-비시클로[3.1.0]헥산 유도체
WO2008103501A1 (en) 2007-02-22 2008-08-28 Irm Llc Compounds and methods for modulating g protein-coupled receptors
EP2151236A4 (en) 2007-04-26 2013-01-16 Japan Science & Tech Agency G PROTEIN COUPLED RECEPTOR AGONIST
WO2009117421A2 (en) 2008-03-17 2009-09-24 Kalypsys, Inc. Heterocyclic modulators of gpr119 for treatment of disease
WO2010048207A2 (en) 2008-10-21 2010-04-29 Metabolex, Inc. Aryl gpr120 receptor agonists and uses thereof
AR074760A1 (es) * 2008-12-18 2011-02-09 Metabolex Inc Agonistas del receptor gpr120 y usos de los mismos en medicamentos para el tratamiento de diabetes y el sindrome metabolico.
US8362052B2 (en) * 2009-03-11 2013-01-29 Msd K.K. Isoindolin-1-one derivative
JP5234029B2 (ja) * 2009-08-05 2013-07-10 山栄化学株式会社 無洗浄活性樹脂組成物及び表面実装技術
WO2011094890A1 (en) 2010-02-02 2011-08-11 Argusina Inc. Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators
US8299117B2 (en) * 2010-06-16 2012-10-30 Metabolex Inc. GPR120 receptor agonists and uses thereof
ES2526124T3 (es) * 2010-06-16 2015-01-07 Cymabay Therapeutics, Inc. Agonistas del receptor GPR120 y sus usos
WO2013019635A1 (en) 2011-07-29 2013-02-07 Tempero Pharmaceuticals, Inc. Compounds and methods
EA027781B1 (ru) 2013-03-14 2017-08-31 Янссен Фармацевтика Нв Бензоконденсированные гетероциклические производные, подходящие для использования в качестве агонистов gpr120

Also Published As

Publication number Publication date
CN105209444B (zh) 2017-12-29
IL267196A (en) 2019-08-29
ES2673921T3 (es) 2018-06-26
MX2015012094A (es) 2016-04-15
KR102422559B1 (ko) 2022-07-18
US9562053B2 (en) 2017-02-07
IL240643B (en) 2019-06-30
ES2836053T3 (es) 2021-06-23
AU2018214053A1 (en) 2018-08-23
JP2019094341A (ja) 2019-06-20
AU2014241397B2 (en) 2018-05-10
KR20150127722A (ko) 2015-11-17
EP3421458B1 (en) 2020-11-11
BR122021021616B1 (pt) 2022-08-30
UA117241C2 (uk) 2018-07-10
CN105209444A (zh) 2015-12-30
JP6802302B2 (ja) 2020-12-16
WO2014159061A3 (en) 2015-01-15
EP2970157B1 (en) 2018-04-25
KR20210050601A (ko) 2021-05-07
US20190152937A1 (en) 2019-05-23
PH12019500467A1 (en) 2020-11-04
NZ751217A (en) 2020-07-31
KR102249047B1 (ko) 2021-05-07
US10730847B2 (en) 2020-08-04
CA2905293A1 (en) 2014-10-02
EA027781B1 (ru) 2017-08-31
IL267196B (en) 2021-06-30
PL2970157T3 (pl) 2019-02-28
CA2905293C (en) 2021-10-12
EP2970157A2 (en) 2016-01-20
US11254647B2 (en) 2022-02-22
US20170088531A1 (en) 2017-03-30
DK2970157T3 (da) 2018-07-16
US20140275172A1 (en) 2014-09-18
NZ711191A (en) 2019-05-31
EP3421458A1 (en) 2019-01-02
JP2016516690A (ja) 2016-06-09
US20200317629A1 (en) 2020-10-08
PH12015501941A1 (en) 2016-02-01
PL3421458T3 (pl) 2021-04-19
AU2018214053B2 (en) 2020-03-12
BR112015022290A2 (pt) 2017-07-18
SG10201709565QA (en) 2017-12-28
PH12015501941B1 (en) 2016-02-01
WO2014159061A2 (en) 2014-10-02
JP6479751B2 (ja) 2019-03-06
UA123269C2 (uk) 2021-03-10
AU2014241397A1 (en) 2015-09-03
EA201591734A1 (ru) 2016-03-31
BR112015022290B1 (pt) 2022-03-03
SG11201507240RA (en) 2015-10-29
US10155737B2 (en) 2018-12-18
IL240643A0 (en) 2015-10-29

Similar Documents

Publication Publication Date Title
DK3442980T3 (da) Heterocykliske forbindelser som ret-kinase-hæmmere
DK3371190T3 (da) Heterocykliske forbindelser som pi3k-gamma-inhibitorer
DK3527263T3 (da) Bipyrazolderivater som jak-inhibitorer
DK3299368T3 (da) Hidtil ukendte aminopyrimidinderivater
DK3342771T3 (da) Heterocykliske amider som kinaseinhibitorer
DK3071203T3 (da) Tetrahydroquinolinsammensætninger som bet-bromdomæne-inhibitorer
DK3164130T3 (da) Heteroaryle forbindelser anvendelige som inhibatorer af sumo-aktiverende enzym
DK3019496T3 (da) Pyrimidinderivater som kinaseinhibitorer
DK3003038T3 (da) 2h-1,2,3-triazolderivater som inhibitorer af fibrose
DK2988743T3 (da) Heterocykliske forbindelser, der kan anvendes til behandling af sygdom
DK3356345T3 (da) Heteroaryl-derivater som sepiapterin-reduktase-inhibitorer
DK3013796T3 (da) Biarylderivater som gpr120-agonister
DK3201206T3 (da) Borsyrederivater
DK3068776T3 (da) Inhibitorer af replikation af influenzavira
DK3054936T3 (da) 4-((2-hydroxy-3-methoxybenzyl)amino) benzensulfonamid derivater som 12-lipoxygenase inhibitorer
DK3021839T3 (da) Sammensætninger for behandling af fibrose
IL267196B (en) Benzo-fused heterocyclic compounds used as gpr120 agonists
DK3063264T3 (da) Tørring af mikroorganismer
DK3672977T3 (da) Boronsyrederivater
DK3418273T3 (da) Derivater af flavagliner
DK3319970T3 (da) Pyrido-oxazinonderivater som tnap-hæmmere
DK3138840T3 (da) Thiadiazolidin-derivat som anti-enterovirus 71
DK3280920T3 (da) Reversibel forbindelse af maskinkomponenter
DK3027594T3 (da) 2-benzoylaminobenzamidderivater som bcl-3-hæmmere
DE202013102236U8 (de) Haltevorrichtung